LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE™ Navigation and Visualization Platform

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

LUMA-Vision

More Like This

PR Newswire associated0

LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform

PR Newswire associated0

LUMA Vision Expands Clinical Use of VERAFEYE™ in Guiding AF Ablations and Completes Key 510k Submission.

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

PR Newswire associated0

Precision Redefined: LUMA Vision Completes VERAFEYE™ 4D-Guided Persistent AF Ablations, Demonstrating a Significant Advancement in Simplifying Image-Guided Cardiac Care

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio

PR Newswire associated0

Mindray Debuts Next-Generation BeneVision V Series Patient Monitoring System at Euroanaesthesia 2025

LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision